Science Media Centre

Science Media Centre

In the News

Inside the immunotherapy revolution – In the News

Sarah-Jane O'Connor posted in on May 30th, 2017.

New Zealand researchers are at the forefront of the latest war on cancer: immunotherapy. NZ Herald science reporter Jamie Morton goes inside the revolution. An excerpt (read in full…) “Let’s not mince words: it’s a barn-storming, breathless revolution.” Professor Graham Le Gros doesn’t mean to come off sounding over the top. It’s just he’s palpably […]

UPDATED: GMO virus approved for cancer trial – Expert reaction

John Kerr posted in on October 29th, 2015.

The Environmental Protection Authority (EPA) has approved the use of a genetically modified virus (Pexa-Vec) for a liver cancer treatment trial. The Pexa-Vec virus is the first genetically modified organism for a human therapeutic purpose that is capable of reproducing itself, to be approved by the EPA for release under the HSNO Act. In a separate media release Environment Minister […]

New melanoma drug in the headlines

John Kerr posted in on September 8th, 2015.

A promising melanoma drug has doctors and patient groups calling for the medicine to be funded by PHARMAC in New Zealand. There has been a flurry of media coverage following a feature story about pembrolizumab on the current affairs show 3D. The drug, marketed as Keytruda, helps the patient’s immune system to fight certain types […]

Continue reading “New melanoma drug in the headlines

New viral immunotherapy for skin cancer completes phase 3 trials – Expert Reaction

Peter Griffin posted in on May 27th, 2015.

A new drug that specifically targets cancer cells has shown promising results in phase three clinical trials. A genetically-modified herpes virus injected into tumours of melanoma patients stimulated an immune response to attack cancer cells, according to research published in the Journal of Clinical Oncology. The virus replicated inside the cancer cells and used the body’s own immune system […]

Copyright 2017 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy